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0022-2836/$ - see front matter © 2008 ECorticosteroids are transported in the blood by a serpin, corticosteroid-
binding globulin (CBG), and their normally equilibrated release can be
further triggered by the cleavage of the reactive loop of CBG.We report here
the crystal structures of cleaved human CBG (cCBG) at 1.8-Å resolution and
its complex with cortisol at 2.3-Å resolution. As expected, on cleavage, CBG
undergoes the irreversible S-to-R serpin transition, with the cleaved reactive
loops being fully incorporated into the central β-sheet. A connecting loop of
helix D, which is in a helix-like conformation in native CBG, unwinds and
grossly perturbs the hormone binding site following β-sheet expansion in
the cCBG structure but shifts away from the binding site by more than 8 Å
following the binding of cortisol. Unexpectedly, on cortisol binding, the
hormone binding site of cCBG adopts a configuration almost identical with
that of the native conformer.We conclude that CBG has adapted an allosteric
mechanism of the serpins to allow equilibrated release of the hormones by a
flip–flop movement of the intact reactive loop into and out of the β-sheet.
The change in the hormone binding affinity results from a change in the
flexibility or plasticity of the connecting loop, which modulates the confi-
guration of the binding site.© 2008 Elsevier Ltd. All rights reserved.Keywords: thyroxine-binding globulin; corticosteroid-binding globulin;
serpin; cortisol; allosteric mechanismEdited by R. HuberIntroduction
Thyroxine and the corticosteroid hormones are
carried in the blood and released in the tissues by
thyroxine-binding globulin (TBG) and corticoster-
oid-binding globulin (CBG).1,2 Both proteins are
non-inhibitory members of the serpin family of
serine protease inhibitors.3–5 Recent crystallographic
studies (Fig. 1a and b) have shown how the hor-
mones bind similarly to the equivalent pocket on the
surface of each of the two binding globulins.6,8 Bin-
ding and release of the hormones normally occur in a
reversible equilibrium that ensures their appropriate
tissue concentration. However, this balanced equili-
brium, in both TBG andCBG, can exceptionally tip to
favour release of the hormones in the proteolyticess:
steroid-binding
thyroxine-binding
lsevier Ltd. All rights reservemilieu that occurs at sites of inflammation. Although
TBG and CBG have lost their function as protease
inhibitors, the exposed reactive centre peptide loops
of both proteins are susceptible to proteolytic clea-
vage by the elastases and other proteases released by
inflammatory cells.9,10 Cleavage of the loop results in
the profound S-to-R conformational change that ty-
pifies serpins.11,12 The cleaved loop will predictably
be fully incorporated as an extramiddle strand in the
main β-sheet of the molecule with an accompanying
transition in the overall conformation of themolecule
from an initial stressed S state to a more ordered
relaxed R state. This S-to-R change in CBG results in
a 10-fold decrease in its binding affinity for corticos-
teroids, with their consequent release at sites of
inflammation. A similar but less marked (3-fold)
decrease in affinity occurs with the S-to-R change in
TBG, similarly resulting in the release of thyroxine at
inflammatory sites.13 However, little is known about
how exactly the S-to-R conformational changes of the
serpins affect the hormone binding site. Recent
crystal structures of hormone-complexed native
TBG and CBG show that there is unlikely to be anyd.
Fig. 1. Structures of CBG and
TBG. (a) Native rat CBG–cortisol
complex structure6 has a closed
five-stranded A-sheet (red) with the
connecting loop (green) on top of
helix D in a helical conformation. (b)
TBG–thyroxine complex has a par-
tially opened A-sheet with the reac-
tive loop (yellow) partially inserted.
Missing residues of the reactive loop
in the structures are shown as dashed
lines, and the protease cleavage site is
arrowed. The structures of cCBG (d)
and its complex with cortisol (c)
show that the reactive loop (yellow)
is fully incorporated in the central β-
sheet with helix D partially un-
wound. The changes in helix D of
CBG mirror similar changes in
antithrombin: the connecting loop
adopts a two-turn helical conforma-
tion when heparin is bound (e) but
unwinds due to steric hindrance
when the reactive loop is partially
inserted into the A-sheet (f). Helix H
is in cyan and helix A is in blue in
(a)–(d), whereas helix D in E and F is
in light blue. Cortisol and thyroxine
are shown in spheres. For clarity,
helix F of antithrombin is not shown.
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Table 1. Crystallographic data collection and refinement
statistics
cCBG cCBG–cortisol
Data collection
Space group P1 P1
Unit cell parameters
(a, b, c, α, β, γ)
39.94 Å, 39.74 Å,
112.11 Å, 81.94°,
84.06°, 65.39°
38.67 Å, 39.78 Å,
111.59 Å, 83.03°,
85.70°, 69.42°
Solvent content (%) 34 34
Molecules per ASU 2 2
Resolution range 55.4–1.8 (1.94–1.84) 19.4–2.3 (2.42–2.3)
Unique reflections 51,706 (7408) 22,575 (3631)
Average redundancy 2.2 (2.2) 2.2 (2.2)
246 Mechanism of Hormone Releasedirect contact between the cleaved reactive loop and
the hormone binding site. It has been proposed by
Klieber et al. that helix D of CBG could be involved in
regulating hormone binding.6 Here we report
structures of human cleaved CBG (cCBG) and its
complex with cortisol that show how the reactive
loop insertion induces the partial unwinding of helix
D and how the unwound loop interacts with the
hormone binding site. The findings demonstrate the
plasticity of the binding site that allows the normal
equilibrated binding and release of hormones from
the circulating intact binding globulin.Completeness (%) 96.0 (94.1) 93.5 (91.1)
Average I/σ 8.7 (1.5) 11 (2.5)
Rmerge 0.071 (0.420) 0.082 (0.458)
Rmeas 0.097 (0.499) 0.116 (0.648)
Refinement statistics
No. of residues 721 722
No. of refined atoms 6037 5892
No. of solvent
molecules
290 167
R 0.192 0.210
Rfree 0.241 0.271
RMS bond length (Å) 0.010 0.006
RMS bond angles (°) 1.273 0.973
Ramachandran
diagram (%)a
92.8, 7.2, 0, 0 90.9, 9.1, 0, 0
Mean B-factor 27.9 28.5
PDB code 2VDX 2VDY
a Percentages of residues in most favoured region, additional
favoured region, generously favoured region, and disallowed region.Results and Discussion
S-to-R crystal structures
Recombinant human CBG, with the reactive loop
substituted to allow specific thrombin cleavage, was
prepared from Escherichia coli using the SUMO fusion
expression system. Thermal stability studies con-
firmed that the conformational properties of the re-
combinant product were unchanged with unfolding
starting on incubation at 50 °C for 30 min and in the
presence of cortisol at 55 °C. The marked increase in
stability on reactive loop cleavage, with the cCBG
unfolding at 80 °C, confirmed a typical S-to-R tran-
sition (Supplementary Fig. S1). The crystal structure of
cCBG was solved at 1.8-Å resolution with good geo-
metry, and the structure of its complex with cortisol
was solved at 2.3-Å resolution from a cCBG crystal
soaked with a high concentration of cortisol (Table 1).
The features of these structures are compared with
previous structures and analysed as follows:
1. Reactive loop insertion and partial unwinding
of helix D. As expected, cCBG is shown to
undergo the typical overall S-to-R conforma-
tional changes observed with other inhibitory
serpins, with the full incorporation of the
exposed reactive loop into the central β-sheet
A (Fig. 1c and d). A striking feature of the
structure of native rat CBG–cortisol6 is that the
connecting loop on top of helix D, linking it to
strand 2 of β-sheet A, adopts a helix-like
conformation (Fig. 1a). The cCBG structure
solved here shows how steric shifts resulting
from the β-sheet expansion cause an unwind-
ing of this connecting loop. The loop is flexible
and only visible in one molecule in the
asymmetric unit of the cCBG crystal, where it
bends towards and interacts with the rim of the
cortisol binding site (Fig. 1d), resulting in slight
shortening of strand 2 of theAβ-sheet (Fig. 2b).
This partial unwinding of helix D parallels that
observed with the modulation of antithrombin
by heparin.14,15 Antithrombin is a structurally
well-studied serpin, and its A β-sheet can
partially open and close in coordination with
the movement of the reactive centre loop into
and out of the sheet (Fig. 1e and f; Supplemen-tary Movie 1). This movement is allosterically
influenced by the binding of a heparin penta-
saccharide to helix D, which causes a two-turn
extension of the helix and the closure of the A-
sheet (Fig. 1e and f).
2. Hormone binding sites of the complexes. In
keeping with observations that the S-to-R
transition results in a decrease rather than
complete loss of binding affinity, crystals of
cCBG readily formed complexes with cortisol
on soaking. The structure of the complex (Fig.
1c) revealed clear electron density for the
bound hormones (Supplementary Fig. S2) in a
hydrophobic pocket equivalent to that in TBG
and to the site previously described for native
rat CBG (Fig. 2a). As with native rat CBG, the
key interaction in cCBG is with Trp371, which
stacks with the rings of cortisol and addition-
ally hydrogen bonds to conserved residues
such as Gln232 and Asn264. Interestingly, the
cortisol in the second molecule in the asym-
metric unit of the cCBG–cortisol crystal binds
to the hydrophobic pocket in a slightly
different orientation and forms a direct hydro-
gen bond with the indole nitrogen of Trp371
(Supplementary Fig. S2b). The human CBG
structure differs in relevant detail from that of
rat CBG in the presence of an extra hydrogen
bond to the cortisol formed by a histidine
(His368) in human CBG that is substituted by
a lysine in rat CBG (Fig. 2a). This fits with the
Fig. 2. Comparison of the structures of CBG. (a) Overlaid structures of rat CBG–cortisol (brown) and cCBG–cortisol
(green) showing the cortisol (in sticks) in the binding pockets. Structures were superimposed by aligning helix A and
strands 4 and 5 ofβ-sheet B (residues 363–380 of cCBG).Most residues involved in binding cortisol are conserved across the
species. HumanCBGhas a histidine residue at 368 that forms an extra hydrogen bondwith cortisol in contrast to a lysine in
rat CBG. (b) Electron density of the connecting loop on top of helix D in cCBG (contoured at 1 times the rms of themap). The
electron density of the same loop in the cCBG–cortisol structure is shown in Supplementary Fig. S3. (c) The structure of the
cCBG–cortisol complex (in cyan) was overlaid with the structure of cCBG (in green) by aligning helix A and helix H.
Cortisol is shown in gray spheres. Serine 100 forms a main chain hydrogen bond (black dashed line) with Asn238 in the
cCBG structure, but it moves away from the binding pocket by more than 8 Å following cortisol binding. The side chain of
Trp371 rotates about 90° to accommodate cortisol binding. Leu93 (gray) of helixD is located close to the binding site, and its
mutation to a bulkier histidine will affect cortisol binding as seen with the human variant.7 Asn238 is glycosylated in CBG,
which may play a role in modulating the hormone binding site.
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248 Mechanism of Hormone Releaseknown preferential binding of cortisol as
compared with corticosterone by human CBG
but not by rat CBG.16 However, an unexpected
finding apparent on superposing helices A and
H of the binding pocket of native rat CBG and
cCBG–cortisol complexes was that there are
only slight conformational differences in the
binding site following the reactive loop inser-
t ion, with most of the hydrophobic
and hydrogen bonding interactions being
retained in the complexed cleaved form
(Fig. 2a). Helix H in cCBG is rotated about 10°
from the binding pocket, which results in a
slightly larger pocket in the cleaved confor-
mation, but we suspect that this may reflect a
species difference as human and rat CBG have a
limited (∼60%) sequence identity. Overall, we
conclude that in the presence of excess free
hormones (as under the soaking conditions), the
binding site of cortisol can regain the same
configuration in the relaxed cleaved (R) con-
formation as that of the native serpin. The
difference in affinity between native (S) and
cleaved (R) conformations reflects a change in
the relative populations of different conforma-
tional states of the binding site. The binding site
of the R conformation has a decreased affinity
because it less favourably adopts the high-
affinity binding state (as observed in the cortisol
complex structure) compared with that of the S
conformation.
3. Coupling of the hormone binding site and helix
D. It is evident from the direct comparison of
the two cCBG structures—with and without
bound cortisol, that the plasticity of the
connecting loop on top of helix D directly
affects the hormone binding site. In the cCBG
structure, the connecting loop on top of helix D
bends towards the hormone binding site;
however, once the cortisol is soaked into the
binding pocket, this flexible loop becomes
visible in both copies in the asymmetric unit
of the cCBG–cortisol complex and adopts a
Data reduction.fully extended conformation,
with the alpha carbon atom of Ser100 on top of
the loop shifting away from the binding site by
more than 8 Å (Fig. 2c). Alignment of the H and
A helices of these two structures enables the
coordinated movements of the transition to be
depicted visually as a movie (Supplementary
Movie 2) that demonstrates, more clearly than
words can, the plasticity of the loop. Notably, a
primary binding residue that stacks against the
cortisol in the binding site, Trp371, undergoes
rotation on the binding of cortisol, and this,
along with other interactions at the binding
site, is seen to displace the loop away from the
rim of the binding site. The large movement
and expansion of this loop are accompanied by
an exchange of secondary structures between
strand 2A, which is extended, and helix D,
which is partially unwound (Fig. 2b).Allosteric modulation of hormone binding and
release
Our previous crystallographic study of TBG
concluded that it could undergo, as with antithrom-
bin, a reversible flip–flop change in conformation,
resulting “in a transition of TBG from a high- to a
low-affinity state with an accompanying change in
the equilibrated binding and release of thyroxine.”8
Striking evidence for this antithrombin-like allosteric
linkage between loop movement and ligand binding
site came with the recent findings of Klieber et al.
Their structure of the rat CBG–cortisol complex
shows CBG in its high-affinity conformation, with
the A-sheet closed, the reactive loop expelled, and
helix D, as in heparin-activated antithrombin,
extended by two turns. They reasoned that insertion
of the reactive loop into the sheet, as seen in the
structure of TBG, would result in an unwinding of
the top of helix D with consequent perturbation of
the hormone binding site.6 Our results here support
this deduction and not only show structurally how
this unwound loop interferes with hormone binding
but also emphasise the plasticity of the observed
changes. Recent structures of heparin-activated
antithrombin have demonstrated surprising varia-
bility in the transmission of the changes in the
D-helix to the closure of the sheet and to the ejection
of the reactive loop.15 Similarly, the finding here that
the binding sites in cCBG and TBGwill readily adapt
to allow hormone binding indicates that the transi-
tion results in a change of affinity through a change
in the relative populations of different conforma-
tional states of the binding site, rather than direct
ejection of the bound hormone.
Altogether, the structural studies of TBG, CBG,
and other serpins suggest that dynamic hormone
binding and release, as summarised in Fig. 3, are
modulated by a sequence of reversible loop–sheet
configurations and that the S-to-R transition is only
the last frame of the whole process. The revelations
here of the potential for modulation of hormone re-
lease (Fig. 3) are matched by findings elsewhere that
TBG and CBG are more than just simple hormone
carriers. The analogy with antithrombin strengthens
the conclusion that the in-and-out movement of the
reactive loop is allosterically linked to the reversible
binding and release of the hormones. Such move-
ments of the reactive loop are known from other
serpins to be sensitive to changes in body tempera-
ture. The opening of the A-sheet and further insert-
ion of the reactive loop that occurs with increased
body temperature will predictably result with the
hormone-binding globulins in the allosteric release
of the hormone. This potential to function as a pro-
tein thermocouple fits with the observation with
CBG of decreased binding affinity20 together with a
rise in released (free) plasma cortisol as body tempe-
rature rises above 37 °C. This is further exacerbated
in CBG by a parallel decrease in affinity and increased
release of cortisol due to the fall in pH that occurs in
fever and exhaustion.21 The opening and shutting of
Fig. 3. Mechanism of hormone binding and release. Serpins are known to be able to form a series of conformers with a
range of reactive loop (RCL, in red) and A-sheet configurations. Insertion of the reactive loop and the opening of the
A-sheet are linked to other flexible regions of the serpin molecule, including the binding sites for heparin (hD) and
vitronectin,17 while the resulting changes in flexibility or plasticity of hD (in green), as shown here, directly affect the
hormone binding site. The structures of cCBG, together with other results discussed here, indicate a dynamic sequence,
with native CBG having a limited sheet entry as in frame I with a four-residues-shorter reactive loop compared with TBG
and antithrombin, and high binding affinity. The conformation of native TBG is represented in frame II with an
intermediate affinity for thyroxine but equilibrates towards frame Iwith higher affinitywhen the reactive loop is shortened
by three residues or towards frame III with low affinity when the loop is extended by three residues.18,19 Protease cleavage
of the reactive loop results in its incorporation into the central β-sheet A to form, typically irreversibly, a stable relaxed
conformation (frame IV).
249Mechanism of Hormone Releasethe A-sheet of serpins can also be influenced by
external ligands, as observed with interactions of cell
membrane glycosaminoglycans with antithrombin,
and perhaps even more relevantly with those of the
matrix protein vitronectin with the plasminogen
activator inhibitor PAI-1.17 The challenge now is to
identify comparable tissue factors that may interact
with CBG and TBG in a way that more fully utilises
the potential for their allosteric modulation. An
indication that such specific modulation does occur
is seen with the targeted release of thyroxine to spe-
cific tissues22 and its adaptive release in thermoge-
nesis.23 CBG is known to bind to cell membrane
receptors too, and recent findings with mice gene-
tically deficient for CBG clearly indicate the involve-
ment of CBG in cellular interactions that extend
beyond its function as a transport protein.24Materials and Methods
Materials
Recombinant human CBGwas prepared from the SUMO
expression system with an N-terminus of S11NHHRGLA…,
starting from residue 11 of the mature protein. The reactive
loop of CBG (P14–P1) was replaced with that of antitrypsin
Pittsburgh to facilitate the preparation of the relaxed
conformer of CBG (cCBG).25 This variant is non-inhibitory
towards thrombin and readily cleaved at P1Arg by
thrombin. Detailed procedures for evaluation of different
expression systems and protocols for protein expression,
purification, and characterisation are given in the Supple-
mentary Information online.Crystallisation and data collection
The crystals of cCBG were obtained from sitting drops
containing 1 μl of protein (5 mg/ml in 10 mM Tris–HCl,50 mM NaCl, and 1 mM ethylenediaminetetraacetic
acid, pH 7.4) and 1 μl of precipitant solution [10–20%
PEG (polyethylene glycol) 3350, 0.2 M NaCl, and
50 mM Mes buffer, pH 6]. For soaking in cortisol,
cCBG crystals were transferred into a precipitant
solution containing ∼200 μM cortisol and ∼1% ethanol
and soaked for 12 h. Crystals were cryo-protected with
20% ethylene glycol and flash-cooled in liquid nitrogen.
Diffraction data for cCBG at 1.8 Å were collected at
Daresbury SRS Station 10.1, whereas those for the
cCBG–cortisol complex at 2.3 Å were collected in-house
using a Mar345 image plate area detector mounted on
a Rigaku RUH3R generator equipped with Osmic Blue
optics. Data were processed by MOSFLM26 and scaled
with Scala.27 The structures were solved by molecular
replacement with Phaser28 using coordinates of cleaved
antitrypsin [Protein Data Bank (PDB) code 1QMB]29 as
a search model. Two molecules of cCBG were found in
the asymmetric unit for the cCBG and cCBG–cortisol
structures. The initial models were built in Coot30 and
refined with TLS (translation, liberation, and screw
motion) parameters and non-crystallographic symmetry
restraints where applicable in Refmac5.31 All structures
were refined with good geometry, and the final
refinement statistics are listed in Table 1. The secondary
structure was assigned by the program DSSP.32 Figures
were made with PyMOL using the following coordi-
nates: native human TBG–thyroxine complex (PDB
code 2CEO),8 native rat CBG–cortisol complex (PDB
code 2V6D),6 native antithrombin (PDB code 1E04),33
and antithrombin–heparin complex (PDB code 1AZX).14
Morphing movies were made using the programs
LSQMAN (Uppsala Software Factory) and VideoMach.
For clarity in discussing the structural findings with
respect to previous findings with rat CBG, the
numbering used here for residues in rat CBG is that
for the homologous residues in human CBG.
Accession numbers
Coordinates and structure factors for cCBG and its
complex with cortisol have been deposited in the Research
250 Mechanism of Hormone ReleaseCollaboratory for Structural Bioinformatics PDB with
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